Business · 09/10/20081 min read

FDA Expands Access to Certain Prescription Drugs for Healthcare Entities

The FDA is updating its regulations to enable registered blood establishments and comprehensive hemophilia diagnostic treatment centers that qualify as healthcare entities to distribute specific prescription drugs, aligning with the Prescription Drug Marketing Act of 1987 and Prescription Drug Amendments of 1992.